Case Study: Masterson Holdings

15.07.2020

Back to News & Resources

Masterson Holdings Ltd, the construction group turning over circa £150 million per annum, is deploying fingerprint drug testing across its four operating companies. The Intelligent Fingerprinting test will support the random drug testing of all Masterson Holdings employees from directors to labourers. The system will be used to enforce contractual drug usage policy adherence required by major contractors on construction projects, encourage employee health and safety and also as a fundamental element of the company’s ‘fitness for work’ and proactive employee wellbeing initiatives.

For the full case study (pdf), please click on the image below:

Masterson Holdings Case Study

Related Articles and Resources

View All
Download My Copy
Send

Free Webinar: Safer Drug Testing in the Pandemic

11am | 12 November 2020
(15 mins + Q&A time)
More Info
Terms and Conditions apply
close-link